Table: Brightpath Biotherapeutics -2021/22 parent results

BrightPath Biotherapeutics Co

12/05/2022 07:00

May 12 (Reuters)- 
          Brightpath Biotherapeutics Co., Ltd. 
          PARENT-ONLY FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                 Year ended      Year ended        Year to        NEXT   
              Mar 31, 2022    Mar 31, 2021    Mar 31, 2023      YEAR     
                 LATEST         YEAR-AGO         COMPANY       COMPANY   
                 RESULTS         RESULTS        FORECAST     H1 FORECAST 
  Sales          15 mln           2 mln           5 mln                  
              (+515.3 pct)     (-77.8 pct)     (-67.6 pct)               
  Operating     loss 1.48       loss 1.73       loss 1.64                
  Recurring     loss 1.48       loss 1.74       loss 1.64                
  Net           loss 1.48       loss 1.72       loss 1.64                
  EPS        loss 28.55 yen  loss 36.14 yen  loss 29.63 yen              
  Ann Div          NIL             NIL             NIL                   
  -Q2 Div          NIL             NIL             NIL                   
  -Q4 Div          NIL             NIL             NIL                   
  
  NOTE - Brightpath Biotherapeutics Co., Ltd.. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4594.T